Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Lung and Upper Aerodigestive Cancers Research Group / Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.